0:54

Short lecture by Aaron Hartman, MD (YouTube video) discussing safety considerations for the cholesterol absorption inhibitor ezetimibe. The speaker warns clinicians to inform patients that ezetimibe alters biliary sterol composition and may (very rarely) be associated with increased gallstone risk, can cause a minuscule number of mild transient anemia cases, and very rarely causes transaminase elevations (occasional tripling) prompting guideline-directed cessation; recommends periodic transaminase monitoring.

Chapters

More from Aaron

9:01
youtube.com

Nobody Grows Out of Being Double Jointed

12h ago
53:04
youtube.com

Too Many Gut Fixes Can Undo Your Healing. What Helps It Last | Dr. Sabine Hazan

4d ago
6:54
youtube.com

Sometimes I Treat It Before I Know What Caused It

1w ago
45:33
youtube.com

Your Gut Keeps Its Own Age, and It Can Get Younger

1w ago
6:53
youtube.com

Lyme Is Supposed to Be Diagnosed Without a Blood Test

2w ago
1:18
youtube.com

Women’s Heart Attack Symptoms Differ From Men’s 95% of the Time — Only 30% Have Chest Pain #shorts

2w ago
1:42
youtube.com

Heart Disease Kills More Women Than All Cancers Combined — 80% of Cardiac Research Is on Men #shorts

2w ago
2:03
youtube.com

Women’s Physiology Was Systematically Ignored in Drug Research — The Consequences Are Still #shorts

2w ago
1:03:14
youtube.com

Why Cancer Comes Back Somewhere Else with Dr. Nasha Winters

2w ago
7:10
youtube.com

How Mold Became Too Common to Take Seriously

3w ago
2:37
youtube.com

It Took the FDA 20 Years to Realize Women Need Half the Dose of Ambien #shorts

3w ago
See all content